It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

The quip was seemingly a dig at Meghan Markle, who raised eyebrows in an episode of her divisive new Netflix show, With Love, ...

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Rosie O'Donnell provides an update on her weight loss journey during a TikTok video posted on Thursday, March 20. The Emmy Award winner shares that she has continued to lose weight since starting ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Rosie O'Donnell is giving an update on her weight loss journey.

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...